tiprankstipranks
Trending News
More News >
Restart Life Sciences (TSE:HEAL)
:HEAL
Canadian Market

Restart Life Sciences (HEAL) Income Statement

Compare
10 Followers

Restart Life Sciences Income Statement

Last quarter (Q2 2025), Restart Life Sciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Restart Life Sciences's net income was C$-203.48K. See Restart Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 11.47K
Gross Profit
C$ 0.00C$ 25.41KC$ -3.79KC$ -5.00KC$ 1.73K
Operating Expenses
C$ 658.51KC$ 1.26MC$ 1.94MC$ 2.93MC$ 1.80M
Depreciation and Amortization
C$ 2.31KC$ 2.94KC$ 3.79KC$ 5.00KC$ 6.82K
EBITDA
C$ -656.20KC$ -1.20MC$ -1.84MC$ -2.68MC$ -25.23M
Operating Income
C$ -658.51KC$ -1.23MC$ -1.94MC$ -2.93MC$ -1.80M
Other Income/Expenses
C$ 883.26KC$ 7.74KC$ -527.00KC$ 249.46KC$ -23.43M
Pretax Income
C$ 224.75KC$ -1.22MC$ -2.47MC$ -2.68MC$ -25.23M
Net Income
C$ 224.75KC$ -1.22MC$ -3.76MC$ -2.68MC$ -25.23M
Per Share Metrics
Basic EPS
C$ 0.01C$ -0.01C$ -0.02C$ -0.02C$ -0.49
Diluted EPS
C$ 0.01C$ -0.01C$ -0.02C$ -0.02C$ -0.49
Weighted Average Shares Outstanding
15.29M 146.78M 136.56M 111.10M 51.15M
Weighted Average Shares Outstanding (Diluted)
16.11M 146.76M 136.56M 111.10M 51.15M
Currency in CAD

Restart Life Sciences Earnings and Revenue History